Renske Hebing

20182019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Efficacious transition from reference infliximab to biosimilar infliximab in clinical practice

Layegh, Z., Ruwaard, J., Hebing, R. C. F., l’ Ami, M. J., van der Weele, W., Nurmohamed, M. T., Krieckaert, C. & Wolbink, G., 1 May 2019, In : International Journal of Rheumatic Diseases. 22, 5, p. 869-873

Research output: Contribution to journalArticleAcademicpeer-review

Implicit and explicit attitudes towards disease-modifying antirheumatic drugs as possible target for improving medication adherence

van Heuckelum, M., Linn, A. J., Vandeberg, L., Hebing, R. C. F., van Dijk, L., Vervloet, M., Flendrie, M., Nurmohamed, M. T., van Dulmen, S., van den Bemt, B. J. F. & van den Ende, C. H. M., 2019, In : PLoS ONE. 14, 8, e0221290.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol

and On behalf of the OMERACT-Adherence Group, 2018, In : Trials. 19, 1, 204.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access